107 related articles for article (PubMed ID: 7977850)
1. Thromboxane A2 receptor antagonism prevents hormonal and cardiovascular responses to mineral acid infusion.
Cudd TA; Wood CE
Am J Physiol; 1994 Nov; 267(5 Pt 2):R1235-40. PubMed ID: 7977850
[TBL] [Abstract][Full Text] [Related]
2. Prostanoid cascade inhibition prevents cardiovascular and adrenocorticotropic responses to mineral acid infusion.
Cudd TA; Wood CE
Am J Physiol; 1993 Jun; 264(6 Pt 2):R1235-41. PubMed ID: 8391758
[TBL] [Abstract][Full Text] [Related]
3. Does thromboxane mediate the fetal ACTH response to acidemia?
Cudd TA; Wood CE
Am J Physiol; 1996 Mar; 270(3 Pt 2):R594-8. PubMed ID: 8780225
[TBL] [Abstract][Full Text] [Related]
4. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
[TBL] [Abstract][Full Text] [Related]
5. Vagal blockade does not prevent adrenocorticotropin, cortisol, and cardiopulmonary responses to thromboxane A2.
Cudd TA
Can J Physiol Pharmacol; 1998 Dec; 76(12):1087-94. PubMed ID: 10326830
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane A2 acts on the brain to mediate hemodynamic, adrenocorticotropin, and cortisol responses.
Cudd TA
Am J Physiol; 1998 May; 274(5):R1353-60. PubMed ID: 9612402
[TBL] [Abstract][Full Text] [Related]
7. Intravenous acid infusion stimulates ACTH secretion in sheep.
Wood CE; Isa A
Am J Physiol; 1991 Jan; 260(1 Pt 1):E154-61. PubMed ID: 1846273
[TBL] [Abstract][Full Text] [Related]
8. The in vivo antiplatelet effects of thromboxane A2 synthase inhibitors are potentiated by simultaneous thromboxane A2/prostaglandin H2 receptor blockade.
Golino P; Ambrosio G; Gresele P; Pascucci I; Ragni M; Russolillo E; Leproux GB; Chiariello M
J Pharmacol Exp Ther; 1993 Aug; 266(2):511-7. PubMed ID: 8355187
[TBL] [Abstract][Full Text] [Related]
9. Does intracarotid PGE2 increase plasma ACTH concentration in conscious adult ewes?
Cudd TA; Wood CE
Am J Physiol; 1991 Sep; 261(3 Pt 1):E395-401. PubMed ID: 1653527
[TBL] [Abstract][Full Text] [Related]
10. Cardiopulmonary responses to HCl infusion are mediated by thromboxane A2 but not by serotonin.
Orr JA; Ernst M; Carrithers J; Shirer HW
Respir Physiol; 1990; 80(2-3):203-17. PubMed ID: 2218101
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular, adrenocorticotropin, and cortisol responses to hypertonic saline in euvolemic sheep are altered by prostaglandin synthase inhibition.
Cudd TA; Purinton S; Patel NC; Wood CE
Shock; 1998 Jul; 10(1):32-6. PubMed ID: 9688088
[TBL] [Abstract][Full Text] [Related]
12. The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemia.
Grover GJ; Schumacher WA
Basic Res Cardiol; 1989; 84(1):103-10. PubMed ID: 2522297
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 does not act at the carotid sinus to mediate cardiovascular, adrenocorticotropin, cortisol, or blood gas responses.
Cudd TA
Can J Physiol Pharmacol; 1998 Feb; 76(2):118-24. PubMed ID: 9635149
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane mediates renal hemodynamic response to infused angiotensin II.
Wilcox CS; Welch WJ; Snellen H
Kidney Int; 1991 Dec; 40(6):1090-7. PubMed ID: 1837063
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II influences the renal hemodynamic response to blockade of thromboxane A2 and prostaglandin H2 receptors.
Yamaguchi Y; Fenoy FJ; Roman RJ; Nasjletti A
J Pharmacol Exp Ther; 1992 Dec; 263(3):905-9. PubMed ID: 1469647
[TBL] [Abstract][Full Text] [Related]
16. The role of the central thromboxane A2 in cardiovascular effects of a phospholipase A2 activator melittin administrated intracerebroventricularly in normotensive conscious rats.
Yalcin M; Ak F; Erturk M
Neuropeptides; 2006 Jun; 40(3):207-12. PubMed ID: 16524625
[TBL] [Abstract][Full Text] [Related]
17. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2 acts at a site perfused by the carotid vasculature to mediate cardiovascular and adrenocortical responses.
Cudd TA; Castellon R; Purinton SC
Can J Physiol Pharmacol; 1997 Apr; 75(4):271-8. PubMed ID: 9196852
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.
Dubé GP; Jakubowski JA; Brune KA; Bemis KG; Kurtz WL
J Pharmacol Exp Ther; 1995 Feb; 272(2):799-807. PubMed ID: 7853197
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane A2 from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats.
Xu H; Korneszczuk K; Karaa A; Lin T; Clemens MG; Zhang JX
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G277-83. PubMed ID: 15647606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
